Precision for Medicine, part of the Precision Medicine Group, announced today that it has executed a binding agreement to acquire ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology. ACT Oncology provides drug development services focused on the design and execution of clinical trials on behalf of innovative life sciences companies and not-for-profit patient organizations.
{iframe}http://www.precisionformedicine.com/2016/03/precision-medicine-acquires-act-oncology/?utm_source=BioHealth+and+Life+Sciences+Update+-+4%2F15%2F16&utm_campaign=4-15&utm_medium=email{/iframe}